| 1 |
CSMA/PECA/GO |
CSMA/PECA/GO
was not toxic and was biocompatible with favorable
breakdown time for cartilage tissue regeneration. |
(161) |
| 2 |
Chitosan/PVA/GO polymer |
Addition of
GO increased the nanofiber’s mechanical
qualities without compromising its biocompatibility. |
(21) |
| 3 |
GO |
TGF-β3 (growth factor)
was adsorbed with no significant
conformational change and better stability. |
(162) |
| 4 |
GO–PLGA hybrid microparticles |
Promotes the development of human embryonic cartilage rudiment
cells into osteogenic cells. |
(22) |
| 5 |
GO-containing
chitosan scaffolds |
Human articular chondrocytes cultured
for prolonged periods
of time after being deposited on nanocomposite scaffolds showed increased
proliferation with increasing GO percent (14 days). |
(23) |
| 6 |
GO-incorporated hydrogels |
Better mechanical strength and compressive modulus
as well
as continued release of TGF-β3. |
(163) |
| 7 |
GO-modified 3D acellular cartilage extracellular
matrix scaffold |
The internal structure and mechanical
characteristics of the
scaffold are improved by GO modification. In vitro, the GO-modified
composite scaffold (2 mg/mL) increases cell adhesion, proliferation,
and chondrogenic differentiation. The composite scaffold displayed
high biocompatibility and a minimal inflammatory reaction in rats
after being implanted subcutaneously. |
(164) |
